The MHRA has dismantled UK-based illicit manufacturing operations producing fake retatrutide and tirzepatide pens, and counterfeit products have been found to contain the wrong dose, the wrong drug, or contaminants
Right now, theres no FDA-approved GLP-1 patch, Dr
The glucagon receptor activation in retatrutide increases energy expenditure and fat oxidation, something semaglutide cannot do
Interim pharmacokinetic and safety updates continue to support the Phase 2 profile, and researchers are closely watching for the larger, longer-duration data that will ultimately shape the regulatory trajectory for the molecule
Advanced workflows such as LC-HRMS/MS, peptide mapping, hydrogen-deuterium exchange MS, and ion mobility MS improve structural characterization and comparability studies
Most common adverse effects are gastrointestinal, but some symptoms can overlap with serious medication warnings